Drug Costs Archives - Page 27 of 35 - ��ýҕ�l Health News

Podcast: KHN’s ‘What The Health?’ Health Law Fix Misses The Spending Bill Train

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Margot Sanger-Katz of The New York Times discuss the apparent demise of bipartisan legislation aimed at shoring up parts of the Affordable Care Act. They also discuss aggressive new efforts by the Food and Drug Administration to regulate tobacco products. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.

March 23, 2018

Poll: Americans Aghast Over Drug Costs But Aren’t Holding Their Breath For A Fix

Almost three-quarters of Americans think the pharmaceutical industry has too much power in the nation’s capital, according to the Kaiser Family Foundation.

By Rachel Bluth

March 23, 2018

Bill Of The Month

Bill Of The Month: For Toenail Fungus, A $1,500 Prescription

How a prescription wiped out one woman’s health reimbursement account, raising questions about prescription drug price tags and about how health care professionals deal (or don’t) with medical costs.

By Shefali Luthra

March 16, 2018

Lifting Therapy Caps Is A Load Off Medicare Patients’ Shoulders

Last month’s budget deal means Medicare beneficiaries are eligible for physical and occupational therapy indefinitely. Plus, prescription drug costs will fall for more seniors.

By Susan Jaffe

March 14, 2018

Patients Overpay For Prescriptions 23% Of The Time, Analysis Shows

Researchers at the University of Southern California analyzed millions of prescriptions and concluded that close to a quarter paid copays that exceeded the cost of the drugs.

By Sydney Lupkin

March 13, 2018

Rising Health Costs, Soaring Drug Prices, Confusing Bills! What’s A Consumer To Do?

KHN correspondent Shefali Luthra answered a wide variety of questions about health care in a Reddit “Ask Me Anything” chat.

March 9, 2018

Podcast: KHN’s ‘What The Health?’ HHS Leaders Take To The Stump

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and new podcast panelist Anna Edney of Bloomberg News discuss this week’s spate of speeches by the leaders of the Department of Health and Human Services. They also discuss the slow progress on health legislation on Capitol Hill intended to fund the government and stabilize the individual insurance market. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.

March 8, 2018

Of ‘Miracles’ And Money: Why Hemophilia Drugs Are So Expensive

The market is flooded with 28 different medications for just 20,000 patients with the hereditary bleeding disorder. Yet intense competition hasn’t worked to bring costs down. Sales amount to $4.6 billion annually in the U.S.

By Jenny Gold

March 8, 2018

Medicaid Nation

States Strive To Curb Costs For A Crucial — But Exorbitant — Hemophilia Treatment

Saving the lives of people with the bleeding disorder can require high doses of expensive blood-clotting factor. Taxpayers foot much of the bill as manufacturers profit enormously.

By Barbara Feder Ostrov

March 6, 2018

Postcard From Sacramento

Cartoon Mascot Masks Nasty Health Care Feud

California’s health insurers trotted out a heart-healthy character with an ulterior motive — taking a dig at drugmakers.

By Pauline Bartolone

Feb. 28, 2018

In An Effort To Curb Drug Costs, States Advance Bills To Prod Feds On Importation

Legislatures in blue and red states alike are considering proposals that would allow them to import prescription drugs from Canada.

By Shefali Luthra

Feb. 16, 2018

FDA Head Vows To Tackle High Drug Prices And Drugmakers ‘Gaming The System’

In an exclusive interview, FDA Commissioner Scott Gottlieb describes what he’s doing to spur competition and bring down drug prices.

By Sarah Jane Tribble and Liz Szabo

Feb. 15, 2018

Trump’s Budget Proposal Swings At Drug Prices With A Glancing Blow

The Trump administration rolled out a list of actions to attack drug prices, but most dance around the edges.

By Sarah Jane Tribble

Feb. 12, 2018

KHN On NPR: The Uniquely American Problem Of High Prescription Drug Costs

Kaiser Health News Editor-in-Chief Elisabeth Rosenthal discusses drug costs with Scott Simon, the host of NPR's Weekend Edition. Listen to the broadcast and read a transcript of that conversation.

Feb. 12, 2018

Enrollment 2018

Podcast: KHN’s ‘What The Health?’ There’s A Really Big Health Bill In That Budget Deal

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Joanne Kenen of Politico and Margot Sanger-Katz of The New York Times discuss the health policy changes included in the just-concluded bipartisan budget deal on Capitol Hill. The panelists also talk about the final enrollment numbers for individual insurance purchased under the Affordable Care Act, and possible drug price proposals in President Donald Trump’s upcoming budget. Plus, Rovner interviews Andy Slavitt, who this week launched a health care advocacy group called “The United States of Care.”

Feb. 9, 2018

As States Target High Drug Prices, Pharma Targets State Lawmakers

In Louisiana, the wining and dining of lawmakers by scores of pharma lobbyists proves a valuable lesson on how to win statehouse votes and influence profits.

By Jay Hancock and Shefali Luthra

Feb. 1, 2018

Podcast: KHN’s ‘What The Health?’ The State Of The (Health) Union

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo and Julie Appleby and Sarah Jane Tribble of Kaiser Health News discuss President Donald Trump’s promises to reduce drug prices in his first State of the Union Address. The panelists also discuss the departure of the director of the Centers for Disease Control and Prevention after conflict-of-interest reports and the efforts by some states to flout the Affordable Care Act.

Jan. 31, 2018

Expert Advice For The Corporate Titans Taking On Health Care

Amazon, Berkshire Hathaway and JPMorgan Chase & Co. are partnering up to address employee health care costs and improve satisfaction. Can they deliver? And would repackaging health insurance involve drones?

By ��ýҕ�l Health News Staff

Jan. 31, 2018

States Face Costly Conundrum: How To Treat Inmates With Hepatitis C

Although the potentially fatal disease is common among the incarcerated, treatment with the latest hepatitis drugs isn't.

By Alex Smith, KCUR

Jan. 23, 2018

Podcast: What The Health? Our First Live Show: What The Health Will Happen In 2018?

In this episode of “What The Health?” — taped before a live audience — panelists discuss the potential federal government shutdown and what may be in store for health in 2018. They are joined by former Medicare and Medicaid head Tom Scully.

Jan. 18, 2018

��ýҕ�l

Trump 2.0

Public Health

Audio Reports

Special Reports

More Topics

Drug Costs